← Leaderboards
Amir A Naqwi
Powerscope, Inc
$5,082,551
Attributed
$5,082,551
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $868.4K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,082,551 · 11
By mechanism
R44$3,411,730 · 4
R43$1,333,867 · 6
R41$336,954 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDoseBaseAerosolsDevicesTechnologyAnimalsPrototypeSafetyBreathingDepositionParticle SizeLiquid SubstanceSolutionsParticleLungFutureAerosolizedNanoparticleSubmicronDrug Delivery SystemsGenerationsGasesClinical Trials
Grant awards (19)
Treatment of Proliferative Vitreoretinopathy using Aerosolized Methotrexate$336,954
R41 · FY2020 · EY · contact PI
Tools for Improved Translation of Novel Inhalable Therapeutics$54,976
R43 · FY2020 · HL · contact PI
Tools for Improved Translation of Novel Inhalable Therapeutics$219,246
R43 · FY2019 · HL · contact PI
Intraocular Aerosol Treatment for Inhibition of Proliferative Vitreoretinopathy$220,350
R43 · FY2014 · EY · contact PI
Intra-pulmonary aerosol delivery for intubated pediatric patients$239,408
R43 · FY2013 · HD · contact PI
Real-time Characterization of Inhaler Doses$381,289
R44 · FY2010 · HL · contact PI
Real-time Characterization of Inhaler Doses$368,711
R44 · FY2009 · HL · contact PI
Airborne Nanoparticles for Therapeutic Applications$302,674
R44 · FY2009 · EY · contact PI
Nanoparticle Generator for Animal Inhalation Experiments$16,250
R44 · FY2009 · HL · contact PI
Airborne Nanoparticles for Therapeutic Applications$380,673
R44 · FY2008 · EY · contact PI
Nanoparticle Generator for Animal Inhalation Experiments$351,355
R44 · FY2008 · HL · contact PI
Airborne Nanoparticles for Therapeutic Applications$471,175
R44 · FY2007 · EY · contact PI
Nanoparticle Generator for Animal Inhalation Experiments$397,223
R44 · FY2007 · HL · contact PI
Real-time Characterization of Inhaler Doses$99,887
R43 · FY2006 · HL · contact PI
Airborne Nanoparticles for Therapeutic Applications$200,000
R43 · FY2005 · EY
Nanoparticle Generator for Animal Inhalation Experiments$100,000
R43 · FY2005 · HL
Airborne Nanoparticles for Therapeutic Applications$200,000
R43 · FY2004 · EY
Crystal Size and Shape Measurement for Insitu Monitoring$269,606
R44 · FY2003 · GM
Crystal Size and Shape Measurement for Insitu Monitoring$472,774
R44 · FY2002 · GM